Treating exploration and prospect on myelodysplastic syndromes / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 85-87, 2013.
Artículo
en Chino
| WPRIM
| ID: wpr-466504
ABSTRACT
The myelodysplastic syndromes (MDS) are a group of clonal heterogeneous disorders of hematopoietic/progenitor.There are differences between Chinese and Western on cytogenetic typing of MDS.The arsenic-containing Chinese herbal formula Qinghuang powder is exact effective in the treatment of MDS.The clinical effect mechanism research indicated that treatment with arsenic-containing Chinese herbal formula had no effect on karyotype status,but resulted in a significant genome wide demethylation.The effective arsenic-concentration in blood is (19.39±10.36) μg/L,which is obviously lower than that in treating APL.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS